Home > News > Nanogen Announces $7.7 Million Common Stock Sale
April 7th, 2004
Nanogen Announces $7.7 Million Common Stock Sale
Nanogen, Inc. announced today that it has sold 900,000 shares of its common stock to institutional investors at a price of $8.60 per share, for gross proceeds of approximately $7.7 million. After deducting fees and expenses, Nanogen will receive approximately $7.4 million from the sale, which was conducted pursuant to Nanogen's shelf registration statement filed in January 2004 and increased by 150,000 shares on April 6, 2004. The sale is expected to close today.
Long Island Capital Alliance Announces Participants for Brookhaven National Laboratory Technology Transfer Capital Forum on May 8: Keynote Speaker Dr. Doon Gibbs, Director of Brookhaven National Laboratory April 16th, 2015
Graphenea embarks on a new era April 16th, 2015
Harris & Harris Group Portfolio Company OpGen Files Amended Registration Statement for Proposed Public Offering April 8th, 2015
Harris & Harris Group Reports Financial Statements as of December 31, 2014 and Posts Annual Letter to Shareholders on Website March 17th, 2015